RxDoctor Payments Data

Christian Bowlin, PA

Physician Assistant · Winston Salem, NCNPI 1730699596

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (53.3%), food and beverage and education — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Medtronic at 31.1% of the total. Among physician assistant clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$22,813in general payments, 2019–2025

Across 289 payments — averaging $78.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$7K
  • Abbott$5K
  • Boston Scientific$5K
  • Saluda Medical Americas, Inc.$4K
  • Nevro Corp.$2K
  • Globus Medical$361
  • plus $101 from 3 others

What the payments were for

  • Travel & lodging$12,16053%
  • Food & beverage$10,07944%
  • Education$5733%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$22,813 in reported general payments places this provider in the 95th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$29,072
Medicare patients
119
Services billed
491

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl93$75,134
Buprenorphine125$34,229
Nucynta ErTapentadol Hcl13$11,622
NucyntaTapentadol Hcl17$9,748
Gabapentin325$6,044
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen261$5,978
Pregabalin289$4,829
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen148$4,238
Tizanidine Hcl176$2,473
Celecoxib51$2,438
Methocarbamol174$2,343
Tramadol Hcl203$2,199
Tramadol Hcl ErTramadol Hcl33$1,887
Duloxetine Hcl104$1,501
Naloxone Hcl17$1,172

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca, Nucynta Er, Nucynta$14$96,504123 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Winston Salem

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →